• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 64-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
XXX-0042609-9/1/1 25-Jan-2002 64ADL99 1000579427 Therapex Canada
 
XXX-0042609-9/1/2 25-Jan-2002 64ADL99 1000579427 Therapex Canada
 
110-7199375-2/1/1 14-Jan-2002 64BCC24 3003099141 siam bheasach Thailand
 
110-7199375-2/1/2 14-Jan-2002 64BCC25 765 M.S.& D. Thailand
 
XXX-0038886-9/1/1 06-Jan-2002 64GCA28 1000406437 Wyeth Medica Ireland Ireland
 
XXX-0039377-8/1/1 06-Jan-2002 64GCY07 3003448236 Schering Mexicana, S.A. De C.V. Mexico
 
310-5108363-7/1/1 21-Jan-2002 64GJP08 1411365 AbbVie Inc. United States
 
XXX-0042435-9/1/1 18-Jan-2002 64HAL99 3003526223 Pharmex Haiti
 
M05-0322252-9/1/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322252-9/2/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322251-1/1/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322251-1/2/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322251-1/3/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322251-1/4/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322251-1/5/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322434-3/1/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322434-3/2/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322434-3/3/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0322434-3/4/1 07-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0108595-1/1/1 07-Jan-2002 64HDL99 3001854561 Laboratoire Glaxo Wellcome France
 
M05-0108588-6/1/1 07-Jan-2002 64HDL99 3002875226 Glaxo Smithkline - Rixensart Belgium
 
M05-0108587-8/1/1 07-Jan-2002 64HDL99 3005023799 UCB Farchim SA Switzerland
 
M05-0108524-1/1/1 07-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/1/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/2/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/3/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/4/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/5/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/6/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323231-2/7/1 08-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
M05-0323233-8/1/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/2/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/3/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/4/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/5/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/6/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/7/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/8/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323233-8/9/1 08-Jan-2002 64HDL99 3002825550 Smihtkline Beecham International (Panama), S.A. Panama
 
M05-0323276-7/1/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/2/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/3/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/4/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/5/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/6/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/7/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0323276-7/8/1 08-Jan-2002 64HDL99 3003878140 GlaxoSmithKline Inc. Canada
 
M05-0108848-4/1/1 08-Jan-2002 64HDL99 3002875226 Glaxo Smithkline - Rixensart Belgium
 
M05-0108862-5/1/1 08-Jan-2002 64HDL99 3003885753 Glaxo Wellcome South Africa (Pty) Ltd. South Africa
 
M05-0108869-0/1/1 08-Jan-2002 64HDL99 1000174169 Smithkline Beecham United Kingdom
 
M05-0323095-1/1/1 28-Jan-2002 64HDL99 3003262904 Glaxo Operations UK Limited United Kingdom
 
XXX-0039305-9/1/1 06-Jan-2002 64LCQ02 3003445736 Rosalia Castro de Perez Colombia
 
110-7969627-4/1/1 31-Jan-2002 64MCY07 3003530863 Ahmed M Elaidy Egypt
 
110-7969627-4/2/1 31-Jan-2002 64MCY12 3003530863 Ahmed M Elaidy Egypt
 
110-7754622-4/1/1 08-Jan-2002 64RCP99 3003467508 Ian Grant Barbados
 
-
-